884 related articles for article (PubMed ID: 24622934)
1. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing.
Vorsters A; Van Keer S; Biesmans S; Hens A; De Coster I; Goossens H; Ieven M; Van Damme P
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196899
[TBL] [Abstract][Full Text] [Related]
3. Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?
Coorevits L; Traen A; Bingé L; Van Dorpe J; Praet M; Boelens J; Padalko E
J Gynecol Oncol; 2018 Jan; 29(1):e8. PubMed ID: 29185266
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of HPV-DNA in cervical smear samples by two different methods: MY09/11 consensus PCR and type-specific real-time PCR].
Sahiner F; Gümral R; Sener K; Yiğit N; Dede M; Yapar M; Kubar A
Mikrobiyol Bul; 2012 Oct; 46(4):624-36. PubMed ID: 23188576
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
Burroni E; Bonanni P; Sani C; Lastrucci V; Carozzi F; ; Iossa A; Andersson KL; Brandigi L; Di Pierro C; Confortini M; Levi M; Boccalini S; Indiani L; Sala A; Tanini T; Bechini A; Azzari C
J Med Virol; 2015 Mar; 87(3):508-15. PubMed ID: 25418873
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of human papillomavirus (HPV) infection in paired urine and cervical smear samples of HIV-infected women.
Jong E; Mulder JW; van Gorp EC; Wagenaar JK; Derksen J; Westerga J; Tol A; Smits PH
J Clin Virol; 2008 Feb; 41(2):111-5. PubMed ID: 18354821
[TBL] [Abstract][Full Text] [Related]
7. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems.
Payan C; Ducancelle A; Aboubaker MH; Caer J; Tapia M; Chauvin A; Peyronnet D; Le Hen E; Arab Z; Legrand MC; Tran A; Postec E; Tourmen F; Avenel M; Malbois C; De Brux MA; Descamps P; Lunel F
J Clin Microbiol; 2007 Mar; 45(3):897-901. PubMed ID: 17229868
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology.
Daponte A; Pournaras S; Mademtzis I; Hadjichristodoulou C; Kostopoulou E; Maniatis AN; Messinis IE
J Clin Virol; 2006 Jul; 36(3):189-93. PubMed ID: 16690350
[TBL] [Abstract][Full Text] [Related]
11. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the clinical performance of restriction fragment mass polymorphism (RFMP) and Roche linear array HPV test assays for HPV detection and genotyping.
Lee HP; Cho W; Bae JM; Shin JY; Shin SK; Hwang SY; Min KT; Kim SN; Lee SJ; Kim SO; Yoo WD; Hong SP
J Clin Virol; 2013 Jun; 57(2):130-5. PubMed ID: 23410688
[TBL] [Abstract][Full Text] [Related]
13. Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus.
Hagihara M; Yamagishi Y; Izumi K; Miyazaki N; Suzuki T; Kato H; Nishiyama N; Koizumi Y; Suematsu H; Mikamo H
J Infect Chemother; 2016 Aug; 22(8):559-62. PubMed ID: 27342077
[TBL] [Abstract][Full Text] [Related]
14. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of human papillomavirus prevalence in women in Eskişehir, Turkey by Pap smear, hybrid capture 2 test and consensus real-time polymerase chain reaction and typing with pyrosequencing method].
Aslan FG; Us T; Kaşifoğlu N; Özalp SS; Akgün Y; Öge T
Mikrobiyol Bul; 2016 Jan; 50(1):73-85. PubMed ID: 27058331
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus detection from human immunodeficiency virus-infected Colombian women's paired urine and cervical samples.
Munoz M; Camargo M; Soto-De Leon SC; Sanchez R; Parra D; Pineda AC; Sussmann O; Perez-Prados A; Patarroyo ME; Patarroyo MA
PLoS One; 2013; 8(2):e56509. PubMed ID: 23418581
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of human papillomavirus DNA detection in samples obtained for routine Chlamydia trachomatis screening.
Söderlund-Strand A; Wikström A; Dillner J
J Clin Virol; 2015 Mar; 64():88-91. PubMed ID: 25728085
[TBL] [Abstract][Full Text] [Related]
18. Could urine testing be the future of cervical cancer screening?
Pathak N; Dodds J; Zamora J
Womens Health (Lond); 2015 Jun; 11(3):265-7. PubMed ID: 26102464
[No Abstract] [Full Text] [Related]
19. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
20. HPV DNA detection in urine samples of women: 'an efficacious and accurate alternative to cervical samples?'.
Pattyn J; Van Keer S; Téblick L; Van Damme P; Vorsters A
Expert Rev Anti Infect Ther; 2019 Oct; 17(10):755-757. PubMed ID: 31519117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
